Rising cancer rates among young adults stem from obesity-related factors affecting all age groups, not just the young. The data shows thyroid, breast, kidney and endometrial cancers — all obesity-linked — are surging across both younger and older populations globally. This epidemic demands immediate action on obesity prevention and lifestyle changes.
The supposed cancer epidemic among young adults is largely manufactured by medical overdiagnosis rather than real disease increases. While diagnoses have doubled since 1992, death rates remain stable, proving that doctors are simply finding more harmless cases. This false alarm often creates unnecessary fear and subjects healthy young people to invasive treatments in some cases.
There's a 1% chance that the FDA or EMA will withdraw approval of Semaglutide for the treatment of obesity by 2027, according to the Metaculus prediction community.
© 2025 Improve the News Foundation.
All rights reserved.
Version 6.17.0